{"groups":[{"description":"Participants were administered a 7 mg loading dose followed by a 3.5 mg maintenance dose twice a week for up to 8 weeks while receiving concurrent cisplatin and RT.","id":"FG000","title":"Phase 1: Group 1"},{"description":"Participants were administered a 14 mg loading dose followed by a 7 mg maintenance dose twice a week for up to 8 weeks while receiving concurrent cisplatin and RT.","id":"FG001","title":"Phase 1: Group II"},{"description":"Participants were administered a 28 mg loading dose followed by a 14 mg maintenance dose twice a week for up to 8 weeks while receiving concurrent cisplatin and RT.","id":"FG002","title":"Phase 2: Group III - MTD"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"0"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"0"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Phase 1: Dose Escalation"},{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"1"}],"type":"Change in treatment"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"23"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"22"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"1"}],"type":"NOT COMPLETED"}],"title":"Phase 2: MTD"}]}